Pulmonx Corporation (LUNG) Tops Q4 EPS by 14c

Pulmonx Corporation (NASDAQ: LUNG) reported Q4 EPS of ($0.25), $0.14 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $22.59 million versus the consensus estimate of $23.21 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.

You May Also Be Interested In

• Mosaic (MOS), Others Lower Following Trump Post on Potash from Belarus
• Credo Technology shares rise on analyst support and conference comments
• Bank of Canada warns new US tariffs may cut Q4 growth below 1%